{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:54:04Z","timestamp":1790056444815,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030107"],"award-info":[{"award-number":["82030107"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273867"],"award-info":[{"award-number":["82273867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jconrel.2026.114759","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:07:29Z","timestamp":1772125649000},"page":"114759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Liposomal particokinetics and intratumoral microdistribution: A quantitative reassessment of the enhanced permeability and retention effect"],"prefix":"10.1016","volume":"393","author":[{"given":"Yifan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114759_bb0005","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114759_bb0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","article-title":"The mechanisms of nanoparticle delivery to solid tumours","volume":"2","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2026.114759_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114759_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0030","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","article-title":"The exit of nanoparticles from solid tumours","volume":"22","author":"Nguyen","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.114759_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114759_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606628","article-title":"Rational design of cancer nanomedicine: nanoproperty integration and synchronization","volume":"29","author":"Sun","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114759_bb0045","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/ncomms2655","article-title":"Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin","volume":"4","author":"Setyawati","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114759_bb0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nnano.2015.342","article-title":"Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery","volume":"11","author":"Matsumoto","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114759_bb0055","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-14-0493","article-title":"Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models","volume":"20","author":"Song","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114759_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120910","article-title":"Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation","volume":"275","author":"Luan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114759_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2012.06.007","article-title":"Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid","volume":"436","author":"Ma","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114759_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00280-013-2209-7","article-title":"Validation of tumour models for use in anticancer nanomedicine evaluation: the EPR effect and cathepsin B-mediated drug release rate","volume":"72","author":"Duncan","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114759_bb0075","doi-asserted-by":"crossref","first-page":"11838","DOI":"10.1038\/ncomms11838","article-title":"Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy","volume":"7","author":"P\u00e9rez-Medina","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114759_bb0080","first-page":"32","article-title":"A comparison of image contrast with (64)Cu-labeled long circulating liposomes and (18)F-FDG in a murine model of mammary carcinoma","volume":"3","author":"Wong","year":"2013","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.114759_bb0085","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.biomaterials.2013.01.014","article-title":"Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging","volume":"34","author":"Yang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114759_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2022.09.007","article-title":"Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models","volume":"351","author":"Jeon","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/bm101046d","article-title":"Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice","volume":"12","author":"Sadekar","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114759_bb0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/bm501438e","article-title":"Near-infrared dye-conjugated amphiphilic hyaluronic acid derivatives as a dual contrast agent for in vivo optical and photoacoustic tumor imaging","volume":"16","author":"Miki","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114759_bb0105","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114759_bb0110","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114759_bb0115","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1021\/acsnano.9b08142","article-title":"Meta-analysis of nanoparticle delivery to tumors using a physiologically based pharmacokinetic modeling and simulation approach","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114759_bb0120","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.nano.2015.07.015","article-title":"Design considerations for nanotherapeutics in oncology","volume":"11","author":"Stylianopoulos","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114759_bb0125","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","article-title":"Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures","volume":"18","author":"Zhu","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114759_bb0130","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addr.2019.05.009","article-title":"Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool","volume":"143","author":"Qi","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114759_bb0135","article-title":"Near-infrared fluorophores with absolute aggregation-caused quenching and negligible fluorescence re-illumination for in vivo bioimaging of nanocarriers","volume":"4","author":"Cai","year":"2022","journal-title":"Aggregate"},{"key":"10.1016\/j.jconrel.2026.114759_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jconrel.2020.09.024","article-title":"The biological fate of orally administered mPEG-PDLLA polymeric micelles","volume":"327","author":"He","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0145","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/j.apsb.2024.04.002","article-title":"Julolidinyl aza-BODIPYs as NIR-II fluorophores for the bioimaging of nanocarriers","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114759_bb0150","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.nano.2015.06.013","article-title":"Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers","volume":"11","author":"Hu","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114759_bb0155","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.3390\/ijms24076615","article-title":"Liposomes in cancer therapy: how did we start and where are we now","volume":"24","author":"Fulton","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114759_bb0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2017.11.020","article-title":"Determination of non-liposomal and liposomal doxorubicin in plasma by LC-MS\/MS coupled with an effective solid phase extraction: in comparison with ultrafiltration technique and application to a pharmacokinetic study","volume":"1072","author":"Xie","year":"2018","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2026.114759_bb0165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-4347(01)00151-7","article-title":"Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with daunoxome","volume":"757","author":"Bellott","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jconrel.2026.114759_bb0170","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.jchromb.2011.10.004","article-title":"Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC","volume":"879","author":"Yamamoto","year":"2011","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2026.114759_bb0175","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2024.10.032","article-title":"Size-dependent translocation and lymphatic transportation of polymeric nanocarriers post intraperitoneal administration","volume":"376","author":"Cai","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114759_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10637-017-0525-1","article-title":"Phase Ib\/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma","volume":"36","author":"Weiss","year":"2018","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.jconrel.2026.114759_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s41207-022-00307-5","article-title":"Predicting COVID-19 future trends for different European countries using Pearson correlation","volume":"7","author":"Muhaidat","year":"2022","journal-title":"EuroMediterr. J. Environ. Integr."},{"key":"10.1016\/j.jconrel.2026.114759_bb0195","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.114759_bb0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2015.04.006","article-title":"Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model","volume":"207","author":"Ekdawi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114759_bb0205","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/bc060064k","article-title":"Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy","volume":"17","author":"Miyajima","year":"2006","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114759_bb0210","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11095-006-9662-5","article-title":"Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors","volume":"23","author":"Khalid","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114759_bb0215","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bjc.6600680","article-title":"Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts","volume":"88","author":"Graff","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114759_bb0220","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1038\/ncomms9692","article-title":"Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug","volume":"6","author":"Miller","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114759_bb0225","doi-asserted-by":"crossref","first-page":"12599","DOI":"10.1021\/acsnano.9b03848","article-title":"Extravasating neutrophils open vascular barrier and improve liposomes delivery to tumors","volume":"13","author":"Naumenko","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114759_bb0230","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1021\/acsnano.1c11578","article-title":"Macrophages actively transport nanoparticles in tumors after extravasation","volume":"16","author":"Lin","year":"2022","journal-title":"ACS Nano"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:59:37Z","timestamp":1781715577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0168365926001616"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114759","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal particokinetics and intratumoral microdistribution: A quantitative reassessment of the enhanced permeability and retention effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114759"}}